drugset / Trial / NCT06108362

Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients

NCT06108362

Phase 4 Unknown 104 enrolled Beijing Tsinghua Chang Gung Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the effect of intraoperative terlipressin on the incidence of early postoperative acute kidney injury in deceased doner liver transplantation. Patients were randomly divided into experimental group and control group by numerical randomization table. The experimental group was injected with terlipressin perioperative and the control group was injected with placebo

Timeline

Start
2023-08-18
Primary completion
2024-06-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 2 ug/kg

Indications